<DOC>
	<DOCNO>NCT00868868</DOCNO>
	<brief_summary>A randomized clinical trial evaluate use pedometer brief exercise coaching prostate cancer patient treat androgen deprivation therapy . The investigator want demonstrate less side effect hormonal therapy well quality life patient make regular exercise .</brief_summary>
	<brief_title>Pedometer Exercise Study Prostate Cancer Patients With Hormonal Therapy</brief_title>
	<detailed_description>To evaluate effectiveness regular exercise well-being patient complete questionnaire sexual function ( IIEF-15 ) quality life . We also perform visit anthropometrics measurement waist , leg arm , weight vital sign . Biochemical analysis prostatic specific antigen do periodically .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>18 year age old Histologically proven prostate cancer Treatment plan administer long term ADT ( androgen deprivation therapy ) . Patient must currently treat ADT least 2 week enrollment trial , 6 month . Patient treat maximum androgen blockade strategy , combine antiandrogen agent LHRH analog agent admissible protocol , patient treat antiandrogen agent alone . Written inform consent participate trial . Known hypersensitivity Zoladex , Casodex ( applicable ) , component product , similar agent Severe cardiac disease ( New York Heart Association class III great ) Severe lung disease Uncontrollable pain Unstable bone lesion Any comorbidity restrain patient 's ability walk alone modify walk habit ( eg Parkinson 's disease , advanced multiple sclerosis , leg amputation , ... ) Any concomitant condition would make undesirable , physician 's opinion , subject participate trial would jeopardize compliance protocol . Any contraindication undertake 6minutes walk test ( unstable angina myocardial infarction previous month , rest heart rate 180 , systolic blood pressure 180 , diastolic pressure 100 ) . The patient must cardiovascular condition stabilize control enrollment trial . Unwillingness incapacity consent trial participation .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2009</verification_date>
	<keyword>Pedometer</keyword>
	<keyword>Prostate</keyword>
	<keyword>Cancer</keyword>
	<keyword>Hormonotherapy</keyword>
	<keyword>Exercise</keyword>
</DOC>